100 related articles for article (PubMed ID: 1020930)
21. [The in vivo penetration of erythromycin into alveolar macrophages].
Carré P; Piva F; Aerts C; Voisin C; Wallaert B
Rev Mal Respir; 1990; 7(2):119-22. PubMed ID: 2320782
[TBL] [Abstract][Full Text] [Related]
22. [Blood-cerebrospinal fluid barrier. I. Permeability of RISA 131 I 24 hours after intravenous administration].
Miyazaki M; Fujita M; Gemba H; Shimazaki K; Kanao K
Rinsho Shinkeigaku; 1974 Mar; 14(3):281-5. PubMed ID: 4472983
[No Abstract] [Full Text] [Related]
23. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
Benfeldt E
Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
[TBL] [Abstract][Full Text] [Related]
24. Entry of tromethamine into the cerebrospinal fluid of humans after cerebrovascular events.
Nau R; Desel H; Lassek C; Kolenda H; Prange H
Clin Pharmacol Ther; 1999 Jul; 66(1):25-32. PubMed ID: 10430106
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
Goudah A; Abo El Sooud K; Abd El-Aty AM
Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
[TBL] [Abstract][Full Text] [Related]
26. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
[TBL] [Abstract][Full Text] [Related]
27. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat.
Kim KS; Wass CA; Cross AS; Opal SM
Lymphokine Cytokine Res; 1992 Dec; 11(6):293-8. PubMed ID: 1477182
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacokinetics of penicillins in the blood of dogs administered the combination preparation, ampiox, internally].
Vasil'ev VK
Antibiotiki; 1976 Nov; 21(11):1000-2. PubMed ID: 1020929
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacokinetics of rifamycin].
Iakovlev VP
Antibiotiki; 1978 Jun; 23(6):526-33. PubMed ID: 677840
[TBL] [Abstract][Full Text] [Related]
30. Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae.
Martínez-Marín C; Huelves L; del Prado G; García-Cía JI; Cenjor C; Ponte C; Granizo JJ; Soriano F
J Antimicrob Chemother; 2005 Oct; 56(4):783-6. PubMed ID: 16144869
[TBL] [Abstract][Full Text] [Related]
31. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis.
Margaritis VK; Ismailos GS; Naxakis SS; Mastronikolis NS; Goumas PD
Am J Rhinol; 2007; 21(5):574-8. PubMed ID: 17999793
[TBL] [Abstract][Full Text] [Related]
32. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis.
Lipman J; Allworth A; Wallis SC
Clin Infect Dis; 2000 Nov; 31(5):1131-3. PubMed ID: 11073740
[TBL] [Abstract][Full Text] [Related]
34. [Penetration of amoxicillin into the cerebrospinal fluid].
Mingrino S; Scanarini M; Magliulo E
Arch Sci Med (Torino); 1981; 138(1):33-5. PubMed ID: 7247702
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration.
Martin R; Schwuléra U; Menke G; Rudolph W; Buch K; Fasold H; Lissner R; Thrun A; Krauseneck P; Bogdahn U
Eur Cytokine Netw; 1992; 3(4):399-406. PubMed ID: 1421012
[TBL] [Abstract][Full Text] [Related]
36. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
37. Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects.
Shiba K; Saito A; Miyahara T
Clin Ther; 1990; 12(3):206-15. PubMed ID: 2379224
[TBL] [Abstract][Full Text] [Related]
38. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
Richards RD; Davenport K; McCallum RW
Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421
[TBL] [Abstract][Full Text] [Related]
39. [Antifibrinolytic therapy of subarachnoid hemorrhage. Permeation of oral paraaminomethylbenzoic acid in the cerebrospinal fluid].
Hindersin P; Heidrich R; Endler S
Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):214-9. PubMed ID: 6968077
[TBL] [Abstract][Full Text] [Related]
40. [Study of the pharmacokinetics of dicloxacillin used parenterally in an experiment].
Vasil'ev VK
Antibiotiki; 1977 May; 22(5):450-4. PubMed ID: 879730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
